Health News

New Leukemia Rx Hits Market
Folks living with two types of blood cancer have new choices as of today. The US Food and Drug Administration has approved Iclusig ( ponatinib ) to treat chronic myeloid leukemia ( CML ) and Philadelphia chromosome-positive acute lymphoblastic leukemia ( Ph + ALL). 
FDA approves Iclusig to treat two rare types of leukemia
The US Food and Drug Administration today approved Iclusig (ponatinib) to treat adults with chronic myeloid leukemia (CML) and Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL), two rare blood and bone marrow diseases.
On The Job With Multiple Myeloma
Exposure to certain chemicals is thought to be a possible cause of a blood cancer called multiple myeloma. Researchers have honed in on this to see how occupation can affect risks.
Concentrated Cruciferous Compound Cuts Cancer
A common blood cancer in children is called acute lymphoblastic leukemia. Most children are cured of the cancer. About one in five kids, though, don’t respond to treatment. A natural alternative may help these youngsters.
Blood's Gone Hormonal
For most women, taking birth control pills is generally safe, and may even provide some protective benefits. However, there is a known risk that "the pill" can cause blood clots, especially in smokers. Is there an impact on women with an ovarian condition?
Treating Cancer in Very High Risk Kids
Remarkable progress has been made in treating childhood leukemia. Many kids who get these blood cancers will beat their disease and live normal lives. Progress is being made in treating a more aggressive and life-threatening form of pediatric leukemia.
Insides Aren't Supposed to Bleed
Bleeding is never a good sign. Though it may not come with pain, having blood in your stools could mean some bigger problem is happening inside and new research is finding more people are getting hospitalized for this problem.
FDA Drug Safety Communication: Important Change to Heparin Container Labels
The US Food and Drug Administration (FDA) is notifying healthcare professionals, caregivers, and patients about a change to the container and carton labels for heparin products, which are blood-thinning agents that prevent the formation of blood clots.
Attacking Leukemia Resistance
Chronic myeloid leukemia ( CML ) is a tricky cancer because it can respond well to initial therapy, but then that drug sometimes stops working. The same thing can happen when different – second-line – drugs are used. The reason for this is that the disease tends to keep changing or mutating.
An Aspirin a Day After Blood Clots
A common treatment after having a blood clot is taking blood thinner medication. But many doctors will eventually take patients off medication when it's no longer necessary. Then what?